# OnCo record eli-lilly (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/eli-lilly/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "eli-lilly" ;
  schema:name "Eli Lilly (incl. Loxo)"@en ;
  schema:description "Eli Lilly makes Verzenio and Retevmo, as well as the oral SERD imlunestrant and the BTK inhibitor pirtobrutinib."@en ;
  schema:url <https://onco.cc/companies/eli-lilly/>, <https://www.lilly.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.lilly.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/hormonal/> ;
  onco:drugs <https://onco.cc/drugs/abemaciclib/>, <https://onco.cc/drugs/selpercatinib/>, <https://onco.cc/drugs/tersolisib/>, <https://onco.cc/drugs/vepugratinib/>, <https://onco.cc/drugs/sofetabart-mipitecan/>, <https://onco.cc/drugs/olaratumab/>, <https://onco.cc/drugs/merestinib/>, <https://onco.cc/drugs/pemetrexed/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/vindesine/> ;
  onco:companies <https://onco.cc/companies/emergence-therapeutics/>, <https://onco.cc/companies/kelonia-therapeutics/>, <https://onco.cc/companies/mablink-bioscience/>, <https://onco.cc/companies/point-biopharma/>, <https://onco.cc/companies/scorpion-therapeutics/>, <https://onco.cc/companies/lilly-ventures/> ;
  onco:trials <https://onco.cc/trials/nct02152631/>, <https://onco.cc/trials/nct02411448/>, <https://onco.cc/trials/nct03706365/>, <https://onco.cc/trials/nct03157128/>, <https://onco.cc/trials/nct07162181/>, <https://onco.cc/trials/nct04280081/>, <https://onco.cc/trials/nct03899792/>, <https://onco.cc/trials/nct04956640/>, <https://onco.cc/trials/nct05768139/>, <https://onco.cc/trials/nct06413706/>, <https://onco.cc/trials/nct01594723/>, <https://onco.cc/trials/nct05440786/>, <https://onco.cc/trials/nct02763566/>, <https://onco.cc/trials/nct05999994/>, <https://onco.cc/trials/nct06119581/>, <https://onco.cc/trials/nct07169851/>, <https://onco.cc/trials/nct06588478/>, <https://onco.cc/trials/nct02107703/>, <https://onco.cc/trials/nct05023980/>, <https://onco.cc/trials/nct07287098/>, <https://onco.cc/trials/nct05254743/>, <https://onco.cc/trials/nct02747004/>, <https://onco.cc/trials/nct04965493/>, <https://onco.cc/trials/nct05288166/>, <https://onco.cc/trials/nct05514054/>, <https://onco.cc/trials/nct04623541/>, <https://onco.cc/trials/nct04662255/>, <https://onco.cc/trials/nct04819100/>, <https://onco.cc/trials/nct06890598/> .